Explore groundbreaking advancements in marine pharmacology, focusing on drug discovery from oceanic organisms. This includes novel anticancer treatments, antibiotics, and other therapeutic compounds derived from marine biotechnology and natural products. Discover the latest research and development in marine-derived medicines and their potential for human health.
Nuevo antibiótico marino
(+2)
Anthracimycin is a marine antibiotic with a unique chemical structure, discovered in 2013 and whose relevance continues to be highlighted in 2024. Its efficacy against resistant bacteria such as MRSA is crucial in the face of the antibiotic resistance crisis.
Aprobada por la FDA para el tratamiento de la leucemia
(+4)
Cytarabine, derived from a marine sponge, is an anticancer drug with a long history and remains essential in the treatment of leukemia. Its lasting efficacy highlights the value of early marine discoveries.
Aprobación como medicamento huérfano para cáncer de pulmón de célula pequeña
(+4)
Lurbinectedin, a synthetic analog of a marine compound, is a current oncological therapy for small cell lung cancer. Its ongoing research and the presentation of new data in 2026 confirm its relevance.
Principio activo anticancerígeno de origen marino
(+3)
Plitidepsin is a compound of marine origin that has proven to be a potent antiproliferative agent in various cancers. Its relevance has been reinforced by its intense antiviral activity against SARS-CoV-2, with clinical trials supporting its potential.
Primer fármaco antitumoral de origen marino
(+3)
Trabectedin is a pioneering antitumor drug of marine origin, developed by a Spanish company. Its established use in the treatment of soft tissue sarcomas and ovarian cancer demonstrates its lasting impact in oncology.
All the rankings you can imagine
Thousands of verified votes to discover the best. Your vote here counts
Análogo sintético de la halicondrina B
(+4)
Eribulin Mesylate is a synthetic analog of a marine sponge compound, approved for the treatment of breast cancer and liposarcoma. Its inclusion highlights the importance of synthetic analogs inspired by marine chemistry.
Poseen diversos efectos beneficiosos
(+4)
Recent research by the University of Malaga on marine seaweed polysaccharides highlights their multifaceted potential. These compounds promise applications in cancer, inflammation, immunomodulation, and photoprotection, opening new therapeutic avenues.
Propiedades antioxidantes
(+4)
The scientific expedition in April 2026 to evaluate the potential of red algae from Morrocoy National Park is a very current innovation. It focuses on the extraction of phycobiliproteins and other bioactive compounds for new medicines.
Primer fármaco contra el alzhéimer aprobado a nivel mundial basado en algas
(+2)
Oligomannate, derived from brown algae, is a crucial innovation in Alzheimer's treatment. Its approval in China and its advancement to Phase III clinical trials in the USA position it as a highly current marine drug.
Estimula la reparación celular
(+1)
Diazepinomicin, a recently discovered metabolite from a marine actinomycete, shows promising broad-spectrum antitumor activity. Its potential against gliomas, prostate, and breast cancer makes it a key candidate.
Descubrimiento de compuestos que inhiben la virulencia de E. coli
(+4)
The discovery of virulence inhibitors in Arctic actinobacteria in 2024 is an innovative strategy against antibiotic resistance. These compounds reduce bacterial pathogenicity without affecting growth, hindering the development of resistance.
Imita la hormona humana somatostatina
(+4)
The recent discovery in August 2024 of a marine snail molecule that mimics somatostatin is a promising innovation. It has great potential for the development of new drugs for diabetes, a highly prevalent disease.